Detail akcie Elekta AB online

Business Summary: Elekta publ AB is a Sweden-based human care company that develops and sells clinical solutions for the treatment of cancer and brain disorder. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. The Company has four product areas: Elekta Neuroscience, which develops solutions for the diagnosis and treatment of neurological diseases; Elekta Oncology, which creates clinical solutions for radiation therapy, such as linear accelerators, integrated imaging systems and clinical solutions for patient positioning and immobilization; Elekta Brachytherapy, which is engaged in the treatment of cancer through internal radiation, and Elekta Software, which develops software solutions for patient information, workflow management and treatment planning in oncology. The Company owns the service business of Asesores Electronicos Especializados SA de CV (AEESA).
Financial Summary: BRIEF: For the nine months ended 31 January 2024, Elekta AB (publ) revenues increased 12% to SEK13.1B. Net income applicable to common stockholders increased from SEK397M to SEK887M. Revenues reflect EMEA segment increase of 18% to SEK4.78B, APAC segment increase of 10% to SEK4.41B, Americas segment increase of 5% to SEK3.91B, EMEA segment increase of 18% to SEK4.78B, APAC segment increase of 10% to SEK4.41B, Americas segment increase of 5% to SEK3.91B.